Clinical trial
The Efficacy of Imipramine in Treatment of Refractory Functional Dyspepsia
NCT00164775 · Chinese University of Hong Kong, Other · Completed
Key facts
| NCT number | NCT00164775 |
|---|---|
| Title | The Efficacy of Imipramine in Treatment of Refractory Functional Dyspepsia |
| Official title | The Efficacy of Imipramine in Treatment of Functional Dyspepsia: A Double Blind Randomized Placebo Controlled Trial |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Functional Gastrointestinal Disorder |
| Intervention type | Drug |
| Interventions | Imipramine, Placebo |
| Enrollment | 107 |
| Start date | Jun 1, 2005 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Sep 14, 2005 |
| Last update posted | Sep 16, 2016 |
| Countries | Hong Kong |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: